BRIEF-Cellectis shares rise 43 pct after signs drug accord with Servier

PARIS Tue Feb 18, 2014 3:27am EST

Related Topics

PARIS Feb 18 (Reuters) - Cellectis SA : * Shares rise 43 percent after the biotechnology company signs a strategic agreement to collaborate with French pharmaceutical group Servier to develop and commercialise new drugs for leukaemia and solid tumours

FILED UNDER: